Internal Medicine, Endocrinology, Diabetes, & Metabolism · Phoenix, AZ
NPI
1528249661
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
240 W Thomas Rd # 404
Phoenix, AZ, 85013
Phone (602) 406-2748
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
3,442 services
Medicare patients, 2024
110
Average age 69
Drug cost, 2024
$3.5M
988 prescriptions
Company payments, 2025
$70K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin C Yuen was code 99215 (office e&m - established), 124 times for 67 patients. In total Kevin C Yuen billed 3,442 services in 28 codes, and Medicare paid $105K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 124 | 67 | $127.69 | $16K |
| 99205 Office E&M - New | Office | 28 | 28 | $162.22 | $4,542 |
| 99214 Office E&M - Established | Office | 24 | 23 | $92.66 | $2,224 |
| 96365 Intravenous Infusion, Hydration | Office | 15 | 12 | $46.47 | $697 |
By year: 2022 $35K for 1,900 services; 2023 $25K for 466 services; 2024 $105K for 3,442 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin C Yuen prescribed most often to Medicare patients was Levothyroxine Sodium, with 150 prescriptions and refills. In total Kevin C Yuen wrote 988 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 150 | 444 | 48 | $1,776 |
| Hydrocortisone Generic | 120 | 262 | 34 | $7,082 |
| Isturisa Osilodrostat Phosphate | 81 | 81 | 11 | $1.2M |
| Genotropin Somatropin | 60 | 63 | Under 11 | $89K |
| Testosterone Generic | 49 | 69 | Under 11 | $11K |
| Sogroya Somapacitan-Beco | 40 | 72 | Under 11 | $169K |
| Prednisone Generic | 37 | 74 | Under 11 | $331 |
| Ozempic Semaglutide | 36 | 53 | Under 11 | $48K |
| Cabergoline Generic | 29 | 66 | Under 11 | $3,420 |
| Mounjaro Tirzepatide | 24 | 31 | Under 11 | $34K |
| Mycapssa Octreotide Acetate | 23 | 23 | Under 11 | $145K |
| Fludrocortisone Acetate Generic | 22 | 28 | Under 11 | $383 |
| Recorlev Levoketoconazole | 22 | 22 | Under 11 | $556K |
| Spironolactone Generic | 21 | 34 | Under 11 | $218 |
| Omnitrope Somatropin | 21 | 29 | Under 11 | $47K |
Brand drugs: 542 claims; generic drugs: 433 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin C Yuen $70K ($65K in general payments such as food, travel and fees and $4,930 for research) from 8 companies. The largest payer was Neurocrine BioSciences, Inc. with $22K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.